Evaluation of Heparin as a potentially interfering substance [Bioanalytics]

posted by Monic  – India, 2019-09-11 14:04  – Posting: # 20584
Views: 1,010

(edited by Monic on 2019-09-11 14:16)

Hi everyone,

Is it required to evaluate the interaction of "heparin" with your analyte of interest during concomitant medication effect as a part of bio-analytical method validation parameter?
since heparin is infused during blood collection to prevent formation of blood clots in clinical phase.

Note: The anticoagulant used for the blood collection in vacutainer is K2EDTA.

Thanks


Edit: Category changed; see also this post #1[Helmut]

Complete thread:

Activity
 Admin contact
20,346 posts in 4,274 threads, 1,402 registered users;
online 5 (0 registered, 5 guests [including 2 identified bots]).
Forum time (Europe/Vienna): 07:27 CET

There are many questions which fools can ask
that wise men cannot answer.    George Pólya

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5